FrontPage is India's Stock Market Social Network
Join 3,00,000+ Traders and Investors

GOKEX Price Target Potential

Arihant Capital Markets50226.91%

GOKEX Ratings

Long term GOKEX rating by FrontPage users
NaN/5 ( Ratings)

GOKEX share price target reports by brokerages below. See what is analyst's view on GOKEX share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
  1. Home
  2. GOKEX Forum
  3. GOKEX Price Target

GOKEX Share Price Target

GOKEX Share Price Target - Broker Reports - 2022

Price @ Call: 409
Target: 502
Price @ Call: 369
Target: 480

GOKEX Share Price Target - Broker Reports - 2021

Price @ Call: 215
Target: 300

GOKEX Share Price Target - Broker Reports - 2020

Price @ Call: 66.3
Target: 81

GOKEX Share Price Target - Broker Reports - 2019

Price @ Call: 80
Target: 116
We adjust our estimates for IND-AS 116 and revise our gross margin assumptions downwards by 150bps in FY20E and 50bps in FY21E due to change in product mix. We expect revenues to grow at CAGR of 18.1% to Rs 16.4bn and adj PAT at 49.1% to Rs 708m over FY19-21E. At CMP, the stock is trading at 9.5FY20E and 4.9x FY21E EPS estimates of Rs 8.6 and Rs 16.5 respectively. We maintain our BUY rating on the stock with revised target price of Rs 116.
... Read more
Price @ Call: 109.2
Target: 132
At CMP, the stock is trading at 12.7x FY20E and 6.6x FY21E earnings. Given robust revenue growth, high return ratios (RoE/RoCE of 22.6%/33.3% in FY21E) and free cash generation, we recommend investors to BUY and TP of Rs 132 (8.0x FY21E EPS).
... Read more
Join FrontPage
Hero Img
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.
FrontPage © 2022